Podcasts
The Future of Oncology: How Public Policy, New Technology and Financial Considerations will Impact Cancer Care
Date:
October 1, 2009
Speaker:
Mark Santos
Description:
With the U.S. healthcare system at an unprecedented crossroads, cancer care has emerged as one of the most hotly debated subjects. Stakeholders include manufacturers, physicians, patients, payers and service providers and even the government itself. And all have their own set of concerns to be addressed.
Join us as we discuss how crucial drivers like health reform, new technology and global economy converge to impact the oncology market. Pharmaceutical Executive Editor-in-Chief Bill Looney visits with Mark Santos, Executive Vice President and General Manager for ION, to discuss this complex industry:
- What can pharmaceutical manufacturers do to maintain product success?
- How can oncologists continue to provide quality care and manage operational costs?
- What role do payers play in the future of oncology?
The Changing Relationship between Pharma and Managed Care
Once viewed as the enemy, managed care has emerged as a necessary stakeholder and even...
Date:
July 07, 2009
Speaker:
Ken Trader
Driving Product Success through Patient Adherence and Compliance
Pharmaceutical manufacturers face unrelenting pressure to grow and protect market share for their products. At...
Date:
May 05, 2009
Speaker:
Jan Nielsen
REMS: Is it the end of the world as we know it? (part 2)
Risk Evaluation and Mitigation Strategies: For manufacturers, do REMS represent a tremendous potential for confusion...
Date:
March 25, 2009
Speaker:
Jay Jackson
REMS: Is it the end of the world as we know it? (part 1)
Risk Evaluation and Mitigation Strategies: For manufacturers, do REMS represent a tremendous potential for confusion...
Date:
February 27, 2009
Speaker:
Peyton Howell